3 Top Growth ETFs to Buy Right Now
Investing in stocks doesn't have to be overly complicated. Exchange-traded funds, or ETFs for short, offer many of the same benefits of owning individual stocks, but these vehicles come with the added bonus of instant diversification. As a result, ETFs can be a straightforward and simple way to gain exposure to the market, or a particular theme like artificial intelligence or genomic medicine, without the risks associated with buying and holding individual stocks.
Which ETFs stand out as strong buys right now? With growth-oriented equities on the mend following the 2022 bear market, the Ark Genomic Revolution ETF (NYSEMKT: ARKG), iShares MSCI Emerging Markets ETF (NYSEMKT: EEM), and iShares Robotics and Artificial Intelligence Multisector ETF (NYSEMKT: IRBO) all screen as attractive buys. Here's a brief overview of each growth ETF.
Image source: Getty Images.
Source Fool.com
MSCI Inc. A Aktie
Die Community sieht MSCI Inc. A positiv: Viel mehr Buy- als Sell-Einschätzungen.
Ein Kursziel von 568 € für MSCI Inc. A signalisiert ein leicht positives Potenzial gegenüber dem aktuellen Kurs von 505.6 €.
